JAN 20, 2016 08:00 AM PST

Extracellular Vesicle Detection and Analysis via Flow Cytometry

Speakers
  • Resource Director Flow Cytometry Core, Beth Israel Deaconess Medical Center/Harvard Stem Cell Institute
    Biography
      After obtaining a degree in Podiatric Medicine from University of Wales, Vasilis's first position was at South County Podiatric Associates, USA. From there, he transitioned to Academic research at Roger William's Hospital (a Brown University teaching hospital) in the Pathology Department. In 2002, Vasilis joined a growing BIDMC Flow Cytometry Core in Boston, MA. There his research interests grew to stem cell biology, landing him as a crucial member of the Harvard Stem Cell Institute. The BIDMC/HSCI current research interests revolve around Small Particle Detection and cutting edge technologies.
    • Technical Director/Manager, Flow Cytometry Core, Beth Israel Deaconess Medical Center/Harvard Stem Cell Institute
      Biography
        After obtaining a degree in the Biological Sciences from Rhode Island College, John obtained certification as an Immunology Specialist from the American Society of Clinical Pathologists. From there, he was recruited to academic research at Roger William's Hospital (a Brown University teaching hospital) in the Pathology and Clinical Immunology Department. In 2001, John became manager of the BIDMC Flow Cytometry Core in Boston, MA. There his research interests grew to stem cell biology, landing him as a crucial member of the Harvard Stem Cell Institute. The BIDMC/HSCI current research interests revolve around Small Particle Detection and cutting edge technologies.

      Abstract:
      Over the past decade, there has been a rapid growth in studies of secreted membrane vesicles, collectively called extracellular vesicles (EVs). (1) The release of EVs has been reported in the pathologies of cancer (2-5), neurological, hematological (6), cardiovascular (7), autoimmune and rheumatologic diseases (8), and viral infections such as malaria (9).  The study of EVs is gaining interest within both the medical and scientific communities due to the diagnostic and therapeutic possibilities. However, the identification and classification of EVs has been problematic.  Although advances in various fields, including microscopy, have addressed some of the preliminary hindrances, flow cytometry remains the dominant approach for the characterization of submicron cell- derived particles. The primary hurdle in analyzing particles at the submicron level has been to accurately represent their size distribution and light scatter profiles. Instrumentation thresholds were originally designed using whole blood as the standard, thereby excluding cellular measurement below 3mm. Recently, flow cytometric technology has been developed to distinguish populations spanning the <400nm to 1mm range.  In this independent study, several of those technologies are evaluated and compared. As most of the hardware adjustments are accomplished by enhancements to the FSC parameter (Beckman Coulter’s MoFlo Astrios EQ and MoFlo XDP with NanoView module), the study will also evaluate the use of Violet SSC on Beckman Coulter’s CytoFLEX as a novel approach to small particle detection. According to Mie theory, it is hypothesized that Violet SSC will give comparable results, as the lower wavelength will allow for detection of smaller particles.
       
      Part 1—Using flow cytometry for vesicles FL and scatter
      Part 2--- Flow cytometric analysis after sorting
       
      1. Jan Lötvall, Andrew F. Hill, Fred Hochberg, Edit I. Buzás, Dolores Di Vizio, Christopher Gardiner, Yong Song Gho, Igor V. Kurochkin, Suresh Mathivanan, Peter Quesenberry, Susmita Sahoo, Hidetoshi Tahara, Marca H. Wauben, Kenneth W. Witwer, Clotilde Théry .  Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. Journal of Extracellular Vesicles. 2014, 3: 26913.
      2. Taylor DD, Gercel-Taylor C. Exosomes/microvesicles: mediators of cancer-associated     immunosuppressive microenvironments. Semin Immunopathol 2011;33(5):441-54
      3. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH.  Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung  Cancer 2009;10(1):42-6 556 8.
      4. Taylor DD, Gercel-Taylor C. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br J Cancer 2005;92(2):305-11
      5. Toth B, Liebhardt S, Steinig K, et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 562 2008;100(4):663-9.
      6. Toth B, Liebhardt S, Steinig K, et al. Platelet-derived microparticles and coagulation activation in breast cancer patients. Thromb Haemost 2008;100(4):663-9.
      7. Kirsty M. Danielson and Saumya Das. Extracellular Vesicles in Heart Disease: Excitement for the Future?. Exosomes Microvesicles, 2014, 2:1. doi: 10.5772/58390.
      8. Sellam J, Proulle V, Jungel A, et al. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 2009;11(5):R156.
      9. Pierre-Yves Mantel, Anh N. Hoang, Ilana Goldowitz, Daria Potashnikova, Bashar Hamza, Ivan Vorobjev, Ionita Ghiran, Mehmet Toner, Daniel Irimia, Alexander R. Ivanov, Natasha Barteneva, Matthias Marti.  Malaria-Infected Erythrocyte-Derived Microvesicles Mediate Cellular Communication within the Parasite Population and with the Host Immune System. Cell Host & Microbe, Volume 13, Issue 5, 15 May 2013, Pages 521-534.
      Learning Objectives:
      • Understand how flow cytometric technology has recently been developed to distinguish extracellular vesicle (EV) populations spanning the <400nm to 1mm range
      • See an independent study comparing several technologies are evaluated and compared

      Show Resources
      You May Also Like
      SEP 05, 2019 04:00 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      AUG 27, 2019 09:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      FEB 26, 2019 09:00 AM PST
      C.E. CREDITS
      FEB 26, 2019 09:00 AM PST
      DATE:  February 26, 2019TIME:   9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
      FEB 27, 2019 08:00 AM PST
      C.E. CREDITS
      FEB 27, 2019 08:00 AM PST
      DATE:  February 27, 2019TIME:  8:00am PST Pluripotent stem cells (PSCs) can form any tissue or cell in the body, and are the ideal starting material to manufacture...
      MAY 16, 2019 04:00 PM CEST
      C.E. CREDITS
      MAY 16, 2019 04:00 PM CEST
      DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
      Loading Comments...
      Show Resources